Volume 14; Issue 3

Expert Opinion on Drug Safety

Volume 14; Issue 3

1

Safety issues and concerns of new immunomodulators in rheumatology

Selmi, Carlo, Ceribelli, Angela, Naguwa, Stanley M, Cantarini, Luca, Shoenfeld, Yehuda

Journal:

Expert Opinion on Drug Safety

Year:

2015

Language:

english

File:

PDF, 297 KB

english, 2015

2

Does hepatitis B virus therapy reduce the risk of hepatocellular carcinoma?

Ridruejo, Ezequiel

Journal:

Expert Opinion on Drug Safety

Year:

2015

Language:

english

File:

PDF, 312 KB

english, 2015

3

Systemic safety of anti-VEGF drugs: a commentary

Scott, Lauren J, Chakravarthy, Usha, Reeves, Barnaby C, Rogers, Chris A

Journal:

Expert Opinion on Drug Safety

Year:

2015

Language:

english

File:

PDF, 429 KB

english, 2015

4

Review of drug safety and efficacy of arformoterol in chronic obstructive pulmonary disease

Loh, Chee H, Donohue, James F, Ohar, Jill A

Journal:

Expert Opinion on Drug Safety

Year:

2015

Language:

english

File:

PDF, 331 KB

english, 2015

5

Safety of subcutaneous versus intravenous tocilizumab in combination with traditional disease-modifying antirheumatic drugs in patients with rheumatoid arthritis

McLaughlin, Maeve, Östör’s, Andrew

Journal:

Expert Opinion on Drug Safety

Year:

2015

Language:

english

File:

PDF, 230 KB

english, 2015

6

Active and passive surveillance of enoxaparin generics: a case study relevant to biosimilars

Grampp, Gustavo, Bonafede, Machaon, Felix, Thomas, Li, Edward, Malecki, Michael, Sprafka, J Michael

Journal:

Expert Opinion on Drug Safety

Year:

2015

Language:

english

File:

PDF, 399 KB

english, 2015

7

Drug-induced lupus

Rubin, Robert L

Journal:

Expert Opinion on Drug Safety

Year:

2015

Language:

english

File:

PDF, 513 KB

english, 2015

8

Assessing safety and efficacy of sofosbuvir for the treatment of hepatitis C

D’Ambrosio, Roberta, Aghemo, Alessio, Colombo, Massimo

Journal:

Expert Opinion on Drug Safety

Year:

2015

Language:

english

File:

PDF, 330 KB

english, 2015

9

Risk-benefit balance assessment of SSRI antidepressant use during pregnancy and lactation based on best available evidence

Weisskopf, Etienne, Fischer, Céline J, Bickle Graz, Myriam, Morisod Harari, Mathilde, Tolsa, Jean-François, Claris, Olivier, Vial, Yvan, Eap, Chin B, Csajka, Chantal, Panchaud, Alice

Journal:

Expert Opinion on Drug Safety

Year:

2015

Language:

english

File:

PDF, 419 KB

english, 2015

10

Pegylated IFN-α-2a and ribavirin in the treatment of hepatitis C infection in children

Pawlowska, Malgorzata

Journal:

Expert Opinion on Drug Safety

Year:

2015

Language:

english

File:

PDF, 176 KB

english, 2015

11

Labetalol for hypertension in pregnancy

Magee, Laura A, Namouz-Haddad, Shirin, Cao, Vivien, Koren, Gideon, von Dadelszen, Peter

Journal:

Expert Opinion on Drug Safety

Year:

2015

Language:

english

File:

PDF, 299 KB

english, 2015

12

Efficacy and adverse effects of drugs used to treat adult cystic fibrosis

Chopra, Ravi, Paul, Lisa, Manickam, Rajapriya, Aronow, Wilbert S, Maguire, George P

Journal:

Expert Opinion on Drug Safety

Year:

2015

Language:

english

File:

PDF, 279 KB

english, 2015

13

A safety assessment of crizotinib in the treatment of ALK-positive NSCLC patients

Dikopf, Alana, Wood, Kevin, Salgia, Ravi

Journal:

Expert Opinion on Drug Safety

Year:

2015

Language:

english

File:

PDF, 283 KB

english, 2015